# Namibia Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Namibia HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Namibia (NAM)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $910.7M
- Products: 18
- Buyer markets: 23
- Average CAGR: +360.6%
- Global sector size: $487.8B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $279.4B | $13.3K | $98.5B | -4.3% | 19 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $67.6B | $5.7K | $25.9B | +18681.7% | 1 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $23.9B | $8.4K | $15.0B | -21.3% | 8 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $21.8B | $396.7 | $13.1B | -10.0% | 7 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $23.2B | $463.8K | $10.0B | +5.5% | 7 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $19.7B | $19.4K | $8.8B | +88.2% | 6 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $11.9B | $104.4K | $7.2B | +35.1% | 6 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $11.2B | $17.5K | $6.9B | +2314.3% | 3 | +0.0% |
| HS 284410 - Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $5.7B | $749.6M | $5.6B | +10.6% | 3 | +14.5% |
| HS 282200 - Cobalt oxides and hydroxides: commercial cobalt oxides | $2.4B | $72.0M | $4.5B | +50.7% | 1 | +2.9% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $4.8B | $52.0 | $2.8B | -7.0% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $4.9B | $131.5 | $2.5B | +9.5% | 3 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $268.5 | $2.2B | +21.2% | 2 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $2.3B | $112.3 | $2.1B | -18.5% | 2 | +0.0% |
| HS 284190 - Salts of oxometallic or peroxometallic acids: n.e.c. in heading no. 2841 | $1.7B | $1.4 | $1.7B | +22.6% | 1 | +0.0% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $1.6K | $1.1B | +7.3% | 1 | +0.0% |
| HS 380893 - Herbicides, anti-sprouting products and plant-growth regulators: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $957.5M | $1.6K | $730.0M | +93.5% | 1 | +0.0% |
| HS 284420 - Uranium: enriched in U235, plutonium, their compounds, alloys dispersions (including cermets), ceramic products and mixtures containing uranium enriched in U235, plutonium or compounds of these products | $1.9B | $88.6M | $660.7M | +11.0% | 1 | +4.6% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $69.8B calculated opportunity across 13 products.
- Switzerland, Liechtenstein (CHE): $30.4B calculated opportunity across 2 products.
- China (CHN): $20.7B calculated opportunity across 7 products.
- Germany (DEU): $12.7B calculated opportunity across 8 products.
- Spain (ESP): $10.0B calculated opportunity across 6 products.
- Canada (CAN): $9.0B calculated opportunity across 6 products.
- United Kingdom (GBR): $8.4B calculated opportunity across 5 products.
- Belgium (BEL): $8.2B calculated opportunity across 2 products.
- Netherlands (NLD): $8.1B calculated opportunity across 2 products.
- France (FRA): $5.0B calculated opportunity across 3 products.
- Japan (JPN): $4.4B calculated opportunity across 2 products.
- Russia (RUS): $4.2B calculated opportunity across 2 products.

## Growth stars

- HS 300215: +18681.7% average CAGR, $25.9B calculated opportunity.
- HS 300212: +2314.3% average CAGR, $6.9B calculated opportunity.
- HS 380893: +93.5% average CAGR, $730.0M calculated opportunity.
- HS 382200: +88.2% average CAGR, $8.8B calculated opportunity.
- HS 282200: +50.7% average CAGR, $4.5B calculated opportunity.
- HS 330300: +35.1% average CAGR, $7.2B calculated opportunity.
- HS 284190: +22.6% average CAGR, $1.7B calculated opportunity.
- HS 300390: +21.2% average CAGR, $2.2B calculated opportunity.
- HS 284420: +11.0% average CAGR, $660.7M calculated opportunity.
- HS 284410: +10.6% average CAGR, $5.6B calculated opportunity.

## Diversification opportunities

- HS 300490: 19 buyer markets, $98.5B calculated opportunity.
- HS 382499: 8 buyer markets, $15.0B calculated opportunity.
- HS 300439: 7 buyer markets, $13.1B calculated opportunity.
- HS 330499: 7 buyer markets, $10.0B calculated opportunity.
- HS 382200: 6 buyer markets, $8.8B calculated opportunity.
- HS 330300: 6 buyer markets, $7.2B calculated opportunity.
- HS 300212: 3 buyer markets, $6.9B calculated opportunity.
- HS 284410: 3 buyer markets, $5.6B calculated opportunity.
- HS 300290: 3 buyer markets, $2.5B calculated opportunity.
- HS 300390: 2 buyer markets, $2.2B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.